title: Metabolic syndrome - Removing roadblocks to therapy: Antigenic immunotherapies.
abstract: Up to 25 per cent of the world׳s adult population may have the metabolic syndrome, a condition closely associated with central obesity. The metabolic syndrome is a major risk factor for cardiovascular disease and type 2 diabetes and therefore represents an important worldwide health problem. In addition to metabolic abnormalities such as raised fasting plasma glucose, high cholesterol and high blood pressure, there is consensus that obese subjects develop a state of low-grade chronic immune activation. This sustained pro-inflammatory response in fat tissue is thought to worsen insulin resistance and dyslipidemia. Likewise, the immune system contributes to the detrimental cascade of events leading to plaque formation in atherosclerosis. It has long been assumed that the innate arm of the immune system was the only key player, but emerging evidence suggests that there is in fact a sizeable adaptive immune component to obesity and cardiovascular disease. From a therapeutic perspective, it could be envisioned that immune modulation drugs such as cytokine inhibitors, co-stimulation blockers or anti-T cell agents could offer benefit. It is questionable, however, whether chronic treatment with for instance biologicals will have a favorable risk/benefit profile in a silent condition such as the metabolic syndrome. An attractive alternative could be the development of antigen-specific T cell therapies, not unlike those currently in various phases of development for type 1 diabetes. In this article, we will give an overview of antigen-specific treatment modalities in type 1 diabetes, followed by a review of the evidence for T cell involvement in obesity and atherosclerosis.
authors.affiliation: Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA.
authors.forename: Ken T
authors.initials: KT
authors.lastname: Coppieters
authors.affiliation: Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA ; Type 1 Diabetes Center, The La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, USA.
authors.forename: Matthias G
authors.initials: MG
authors.lastname: von Herrath
keywords: Antigenic immunotherapies; Atherosclerosis; Macrophages; Metabolic syndrome; Obesity; T cells; Type 1 diabetes; Type 2 diabetes
references.citation: Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2929-37
references.pmid: 21960562
references.citation: Nature. 2005 May 12;435(7039):220-3
references.pmid: 15889095
references.citation: Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443-6
references.pmid: 3463976
references.citation: J Clin Invest. 2006 May;116(5):1371-81
references.pmid: 16628253
references.citation: Mol Cell Biol. 2013 Jan;33(2):328-39
references.pmid: 23149942
references.citation: Circulation. 2002 Sep 24;106(13):1708-15
references.pmid: 12270867
references.citation: J Autoimmun. 2014 May;50:77-82
references.pmid: 24387802
references.citation: Nat Med. 2011 May;17(5):610-7
references.pmid: 21499269
references.citation: J Am Coll Cardiol. 2002 Oct 2;40(7):1333-8
references.pmid: 12383583
references.citation: Lancet. 2010 Jan 16;375(9710):181-3
references.pmid: 20109902
references.citation: PLoS One. 2007 Aug 22;2(8):e779
references.pmid: 17712427
references.citation: Science. 2010 Apr 9;328(5975):228-31
references.pmid: 20203013
references.citation: PLoS One. 2010 Nov 11;5(11):e13951
references.pmid: 21085605
references.citation: Physiol Rev. 2011 Jan;91(1):79-118
references.pmid: 21248163
references.citation: Nat Med. 2009 Aug;15(8):930-9
references.pmid: 19633656
references.citation: Diabetes. 2013 Aug;62(8):2762-72
references.pmid: 23493569
references.citation: Circulation. 2006 Oct 31;114(18):1968-76
references.pmid: 17060383
references.citation: Diabetes Care. 2005 May;28(5):1068-76
references.pmid: 15855569
references.citation: Lancet. 1985 Jan 12;1(8420):67-71
references.pmid: 2857024
references.citation: J Allergy Clin Immunol. 2011 Mar;127(3):654-60
references.pmid: 21377034
references.citation: J Clin Invest. 1999 Jul;104(2):189-94
references.pmid: 10411548
references.citation: Mol Cell Proteomics. 2007 Jul;6(7):1257-73
references.pmid: 17409382
references.citation: Lancet. 2011 Jul 23;378(9788):319-27
references.pmid: 21714999
references.citation: JAMA. 2009 Apr 15;301(15):1573-9
references.pmid: 19366777
references.citation: Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):605-12
references.pmid: 22223728
references.citation: Cell Immunol. 1988 Apr 1;112(2):364-70
references.pmid: 2451570
references.citation: J Exp Med. 2008 Nov 24;205(12):2887-98
references.pmid: 19001136
references.citation: Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1304-10
references.pmid: 18420999
references.citation: Immunotherapy. 2010 May;2(3):289-91
references.pmid: 20635894
references.citation: J Exp Med. 2012 Jan 16;209(1):51-60
references.pmid: 22213807
references.citation: Immunity. 2012 Sep 21;37(3):574-87
references.pmid: 22981538
references.citation: Am J Cardiol. 2006 Jan 16;97(2A):3A-11A
references.pmid: 16442931
references.citation: J Clin Invest. 2012 Sep;122(9):3343-54
references.pmid: 22863618
references.citation: Diabetes. 2010 Jul;59(7):1721-30
references.pmid: 20357361
references.citation: Diabetes. 2012 Jun;61(6):1490-9
references.pmid: 22362174
references.citation: Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):123-7
references.pmid: 8278351
references.citation: Immunome Res. 2013;9(1):
references.pmid: 25140192
references.citation: JAMA. 2007 Jul 18;298(3):285; author reply 285-6
references.pmid: 17635886
references.citation: Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10252-6
references.pmid: 1946445
references.citation: Nat Med. 2006 Feb;12(2):178-80
references.pmid: 16462800
references.citation: Nat Med. 2009 Aug;15(8):914-20
references.pmid: 19633658
references.citation: J Clin Invest. 2006 Nov;116(11):3015-25
references.pmid: 17053832
references.citation: Clin Dev Immunol. 2013;2013:467852
references.pmid: 24222776
references.citation: Clin Exp Immunol. 2007 Apr;148(1):1-16
references.pmid: 17349009
references.citation: Circulation. 1998 Jul 28;98(4):300-7
references.pmid: 9711934
references.citation: Science. 1990 Mar 23;247(4949 Pt 1):1465-8
references.pmid: 1690918
references.citation: Clin Exp Immunol. 2003 Oct;134(1):38-45
references.pmid: 12974752
references.citation: Clin Immunol. 2013 Dec;149(3):307-16
references.pmid: 24090708
references.citation: Circulation. 2011 Mar 15;123(10):1083-91
references.pmid: 21357823
references.citation: Ann Neurol. 2008 May;63(5):611-20
references.pmid: 18481290
references.citation: Diabet Med. 1990 Jun;7(5):429-33
references.pmid: 2142040
references.citation: J Clin Invest. 1996 Sep 15;98(6):1324-31
references.pmid: 8823297
references.citation: J Innate Immun. 2010;2(4):316-24
references.pmid: 20375560
references.citation: Front Immunol. 2013 Dec 27;4:493
references.pmid: 24416033
references.citation: N Engl J Med. 2002 May 30;346(22):1685-91
references.pmid: 12037147
references.citation: Immunol Rev. 2011 May;241(1):241-59
references.pmid: 21488901
references.citation: Nat Rev Cardiol. 2009 Jun;6(6):399-409
references.pmid: 19399028
references.citation: Diabetes. 2005 Jul;54(7):2060-9
references.pmid: 15983207
references.citation: Nat Med. 2011 Feb;17(2):179-88
references.pmid: 21217695
references.citation: Rev Diabet Stud. 2012 Winter;9(4):328-37
references.pmid: 23804270
references.citation: N Engl J Med. 2012 Feb 2;366(5):433-42
references.pmid: 22296077
references.citation: J Exp Med. 1996 Dec 1;184(6):2167-74
references.pmid: 8976172
references.citation: J Clin Invest. 1999 Feb;103(4):571-7
references.pmid: 10021466
references.citation: N Engl J Med. 2007 Apr 12;356(15):1517-26
references.pmid: 17429083
references.citation: Cell. 2011 Apr 29;145(3):341-55
references.pmid: 21529710
references.citation: J Exp Med. 2010 May 10;207(5):1081-93
references.pmid: 20439543
references.citation: Science. 2011 Apr 8;332(6026):243-7
references.pmid: 21436399
references.citation: Nat Med. 2009 Aug;15(8):921-9
references.pmid: 19633657
references.citation: Nat Biotechnol. 2012 Dec;30(12):1217-24
references.pmid: 23159881
references.citation: Clin Immunol. 2013 Dec;149(3):345-55
references.pmid: 23490422
references.citation: Sci Transl Med. 2013 Jun 5;5(188):188ra75
references.pmid: 23740901
references.citation: Life Sci. 2006 Aug 8;79(11):1056-61
references.pmid: 16650442
references.citation: Int Immunol. 2013 Nov;25(11):615-22
references.pmid: 24154816
references.citation: Diabetes. 2007 Sep;56(9):2356-70
references.pmid: 17579207
references.citation: Sci Transl Med. 2013 Jun 26;5(191):191ra82
references.pmid: 23803704
references.citation: PLoS One. 2012;7(1):e29949
references.pmid: 22253836
references.citation: Cell Metab. 2013 Mar 5;17(3):411-22
references.pmid: 23473035
references.citation: J Exp Med. 1979 Mar 1;149(3):758-73
references.pmid: 85683
references.citation: J Clin Invest. 2011 Jun;121(6):2111-7
references.pmid: 21633179
references.citation: Thromb Haemost. 2011 Nov;106(5):796-803
references.pmid: 22012002
references.citation: N Engl J Med. 2012 Jul 19;367(3):233-43
references.pmid: 22808958
references.citation: Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3893-7
references.pmid: 7732003